These findings expand the role played by ASC and IL-1 independent inflammasome employments to extraneural proteinopathies of humans and experimental animals and suggest that anti-ASC immunotherapy may contribute to resolving inflammatory diseases and their sequelae. The gene discussed is PYCARD; the disease is proteostasis deficiencies.